Histopathological characterization of retinal arteriovenous crossings

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022263

Enrollment

Registered

2020-06-22

Start date

2020-06-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H34.2

Interventions

Group 1: Analysis of protein expression at retinal arteriovenous crossings

Eligibility

Sex/Gender

All

Age

5 Years to 130 Years

Inclusion criteria

Inclusion criteria: Ocular disease that makes enucleation necessary and the diagnosis of which leaves some retinal material.

Exclusion criteria

Exclusion criteria: No retinal material left.

Design outcomes

Primary

Measure	Time frame
Imaging of protein expression at retinal arteriovenous crossing sites	—

Secondary

Measure	Time frame
Imaging of protein expression at retinal arteriovenous crossing sites	—

Countries

Germany

Contacts

Public ContactGottfried Martin

Universitätsklinikum FreiburgKlinik für Augenheilkunde

gottfried.martin@uniklinik-freiburg.de0761/270-40010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026